Featured Clinical Trials

  • Malignant Glioma (NCT02208362): Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
  • Acute Myeloid Leukemia/ Blastic Plasmacytoid Dendritic Cell Neoplasm
  • (NCT02159495): Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Acute Lymphoblastic Leukemia (NCT02146924): Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia